|Articles|June 24, 2016
Quintiles Launches Continuous Glucose Monitoring Services
The new offering, designed to enhance diabetes trials, combines wearable technology with Quintiles' therapeutic and analytical expertise.
Advertisement
Quintiles announced a new service offering designed to improve diabetes-focused clinical trials. Through the solution, continuous glucose measurements will be monitored by a wearable sensor and wirelessly sent to a receiver, recording readings throughout the day. In the clinical trial setting, such comprehensive and timely glucose visibility can potentially improve patient safety, accelerate clinical development, and provide a basis for differentiated claims.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4